Rigel Pharmaceuticals CEO to deliver company overview at Jefferies Global Healthcare Conference June 3

Rigel Pharmaceuticals CEO to deliver company overview at Jefferies Global Healthcare Conference June 3
Rigel CEO to present at Jefferies

Rigel Pharmaceuticals announced that CEO Raul Rodriguez will present a company overview at the Jefferies Global Healthcare Conference on Wednesday, June 3 at 8:45am ET in New York.

Investors and stakeholders can listen to the presentation via a live webcast, as shared by the company. This conference appearance gives Rigel Pharmaceuticals an opportunity to update the healthcare investment community on recent developments and future outlook.

Rigel Pharmaceuticals has recently participated in major industry events, inviting ASCO Annual Meeting attendees to discuss oncology advancements at booth 33080 in Chicago earlier this year. The company’s partner Kissei also filed a new drug application in Japan for olutasidenib to treat relapsed acute myeloid leukemia patients in a separate regulatory move. These initiatives come as Rigel continues to pursue opportunities for its pipeline in new markets and therapeutic areas.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.